Lineage Cell Therapeutics : Immediate Report -March 24, 2024 at 04:37 am EDT

UNITED STATES


SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C. 20549


FORM 8-K


CURRENT REPORT
...

Related Keywords

New York ,United States ,Washington ,California ,City Of New York ,American ,Georgea Samuel , ,Subsidiary Of The Company ,Commission File Number ,Lineage Cell Therapeutics Inc ,Exchange Commission The ,Governmental Authority ,B Riley Securities Inc ,Cantor Fitzgerald Co ,Company The Prospectus ,Exchange Commission ,Warranties Of The Company ,Placement Shares Of The Company ,Company Or Lineage ,Financial Industry Regulatory Authority Inc ,Public Company Accounting Oversight Board United States ,United States Drug Enforcement Administration ,Securities Exchange ,Termination Of Prior Offering Program ,Consent Of Sheppard Mullin Richter Hampton ,Opinion Of Sheppard Mullin Richter Hampton ,Neither The Company ,Sales Of The Company ,Drug Administration ,Sheppard Mullin Richter Hampton ,Company To Cantor ,Company Of The Placement ,Public Accounting Firm ,Securities Exchange Act ,Cell Therapeutics ,Its Charter ,Principal Executive Offices ,Zip Code ,Telephone Number ,Including Area Code ,Former Name ,Former Address ,Changed Since Last Report ,Securities Act ,Exchange Act ,Material Definitive ,Lineage Cell Therapeutics ,Sales Agent ,Sales Agreement ,Registration Statement ,Under Rule ,New Registration Statement ,New Registration ,Sheppard Mullin Richter ,Controlled Equity Offering Sales Agreement ,Cantor Fitzgerald ,Prior Sales ,Prior Sales Agreement ,Investigational New Drug Application ,Oligodendrocyte Progenitor Cells ,Spinal Cord Injury ,Novel Device ,Annual Report ,Page Interactive Data File ,Regulations K ,Corporate Secretary ,Placement Shares ,Common Shares ,Prospectus Supplement ,Securities Act Regulations ,Issuer Free Writing Prospectus ,Electronic Data Gathering Analysis ,Interactive Data Electronic Application ,Placement Notice ,Business Days ,Trading Day ,Net Proceeds ,Settlement Date ,Depository Trust Company ,Custodian System ,Business Day ,Maximum Amount ,Applicable Time ,Incorporated Documents ,Issuer Free Writing Prospectuses ,Xtensible Business Reporting Language ,Regulations X ,Material Adverse ,Free Writing Prospectuses ,Material Adverse Effect ,Financial Industry Regulatory Authority ,Current Report ,Public Accounting ,Public Company Accounting Oversight Board ,Sarbanes Oxley Act ,United States Food ,Governmental Authorities ,United States Federal Food ,Cosmetic Act ,